세계의 유방 영상 시장 : 기술별, 최종사용자별, 지역별 보고서(2024-2032년)

The global breast imaging market size reached US$ 4.5 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 8.8 Billion by 2032, exhibiting a growth rate (CAGR) of 7.5% during 2024-2032.

Breast imaging refers to the radiological technique of diagnosing breast cancer in both males and females. It involves a range of equipment to screen, detect and determine the location of the tumor and other breast-related infections, lesions and cysts. It also entails various procedures such as mammography, breast biopsy, ultrasound, tactile imaging and Magnetic Resonance Imaging (MRI). The aim of conducting these procedures is to detect the disease at its earliest and most treatable stage. Procedures such as mammography produce digital images in which the brightness, darkness and contrast can be altered as per the requirement, thus making the differentiation between malignant and benign cells simpler. These procedures are considered safe, are non-invasive and cause minimum discomfort to the patient.

Global Breast Imaging Market Trends and Drivers:

The increasing prevalence of breast cancer, along with the rising awareness of the early detection of the disease, is among the key factors driving the growth of the market. Furthermore, the growing geriatric population, which is more susceptible to such ailments, are also contributing to the increased adoption rate of breast imaging procedures. Various technological advancements in the imaging equipment have enabled improved diagnosis of dense breast tissues. Patients are increasingly opting for digital mammography systems that offer high detection rates in comparison to traditionally used analog devices. Additionally, various organizations and healthcare centers are conducting cancer awareness campaigns to educate individuals about breast health and cancer diagnostic measures. Moreover, technological innovations such as the introduction of breast tomosynthesis or 3D mammography, rising healthcare expenditure, growing disposable income, and government initiatives to improve cancer screening and diagnosis are also driving the market growth.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global breast imaging market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on technology and end-user.

Breakup by Technology:

Ionizing Breast Imaging

Mammography

Positron Emission Tomography-Computed Tomography

Molecular Breast Imaging

Positron Emission Mammography

Cone-Beam Computed Tomography

Non-Ionizing Breast Imaging

Breast Ultrasound

Breast MRI

Automated Whole-Breast Ultrasound

Breast Thermography

Electric Impedance Tomography

Optical Imaging

Breakup by End-User:

Hospitals

Diagnostic Imaging Centers

Ambulatory Surgical Centers

Others

Breakup by Region:

North America

United States

Canada

Asia Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The report has also analysed the competitive landscape of the market with some of the key players being Allengers Medical Systems Limited, Aurora Health Care Inc. (Schoen Clinic), Canon Inc., Carestream Health Inc. (Onex Corporation), Delphinus Medical Technologies, Dilon Technologies Inc., Fujifilm Holdings Corporation, GE Healthcare, Hologic Inc., Koninklijke Philips N.V., Micrima Limited, Planmed Oy, Siemens Healthineers AG (Cerner Corporation), Toshiba Corporation, etc.

Key Questions Answered in This Report:

• How has the global breast imaging market performed so far and how will it perform in the coming years?
• What are the key regional markets?
• What has been the impact of COVID-19 on the global breast imaging market?
• What is the breakup of the market based on the technology?
• What is the breakup of the market based on the end-user?
• What are the various stages in the value chain of the industry?
• What are the key driving factors and challenges in the industry?
• What is the structure of the global breast imaging market and who are the key players?
• What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

• 4.1 Overview
• 4.2 Key Industry Trends

5 Global Breast Imaging Market

• 5.1 Market Overview
• 5.2 Market Performance
• 5.3 Impact of COVID-19
• 5.4 Market Forecast

6 Market Breakup by Technology

• 6.1 Ionizing Breast Imaging
  • 6.1.1 Market Trends
  • 6.1.2 Major Types
    • 6.1.2.1 Mammography
    • 6.1.2.2 Positron Emission Tomography-Computed Tomography
    • 6.1.2.3 Molecular Breast Imaging
    • 6.1.2.4 Positron Emission Mammography
    • 6.1.2.5 Cone-Beam Computed Tomography
  • 6.1.3 Market Forecast
• 6.2 Non-Ionizing Breast Imaging
  • 6.2.1 Market Trends
  • 6.2.2 Major Types
    • 6.2.2.1 Breast Ultrasound
    • 6.2.2.2 Breast MRI
    • 6.2.2.3 Automated Whole-Breast Ultrasound
    • 6.2.2.4 Breast Thermography
    • 6.2.2.5 Electric Impedance Tomography
    • 6.2.2.6 Optical Imaging
  • 6.2.3 Market Forecast

7 Market Breakup by End-User

• 7.1 Hospitals
  • 7.1.1 Market Trends
  • 7.1.2 Market Forecast
• 7.2 Diagnostic Imaging Centers
  • 7.2.1 Market Trends
  • 7.2.2 Market Forecast
• 7.3 Ambulatory Surgical Centers
  • 7.3.1 Market Trends
  • 7.3.2 Market Forecast
• 7.4 Others
  • 7.4.1 Market Trends
  • 7.4.2 Market Forecast

8 Market Breakup by Region

• 8.1 North America
  • 8.1.1 United States
    • 8.1.1.1 Market Trends
    • 8.1.1.2 Market Forecast
  • 8.1.2 Canada
    • 8.1.2.1 Market Trends
    • 8.1.2.2 Market Forecast
• 8.2 Asia Pacific
  • 8.2.1 China
    • 8.2.1.1 Market Trends
    • 8.2.1.2 Market Forecast
  • 8.2.2 Japan
    • 8.2.2.1 Market Trends
    • 8.2.2.2 Market Forecast
  • 8.2.3 India
    • 8.2.3.1 Market Trends
    • 8.2.3.2 Market Forecast
  • 8.2.4 South Korea
    • 8.2.4.1 Market Trends
    • 8.2.4.2 Market Forecast
  • 8.2.5 Australia
    • 8.2.5.1 Market Trends
    • 8.2.5.2 Market Forecast
  • 8.2.6 Indonesia
    • 8.2.6.1 Market Trends
    • 8.2.6.2 Market Forecast
  • 8.2.7 Others
    • 8.2.7.1 Market Trends
    • 8.2.7.2 Market Forecast
• 8.3 Europe
  • 8.3.1 Germany
    • 8.3.1.1 Market Trends
    • 8.3.1.2 Market Forecast
  • 8.3.2 France
    • 8.3.2.1 Market Trends
    • 8.3.2.2 Market Forecast
  • 8.3.3 United Kingdom
    • 8.3.3.1 Market Trends
    • 8.3.3.2 Market Forecast
  • 8.3.4 Italy
    • 8.3.4.1 Market Trends
    • 8.3.4.2 Market Forecast
  • 8.3.5 Spain
    • 8.3.5.1 Market Trends
    • 8.3.5.2 Market Forecast
  • 8.3.6 Russia
    • 8.3.6.1 Market Trends
    • 8.3.6.2 Market Forecast
  • 8.3.7 Others
    • 8.3.7.1 Market Trends
    • 8.3.7.2 Market Forecast
• 8.4 Latin America
  • 8.4.1 Brazil
    • 8.4.1.1 Market Trends
    • 8.4.1.2 Market Forecast
  • 8.4.2 Mexico
    • 8.4.2.1 Market Trends
    • 8.4.2.2 Market Forecast
  • 8.4.3 Others
    • 8.4.3.1 Market Trends
    • 8.4.3.2 Market Forecast
• 8.5 Middle East and Africa
  • 8.5.1 Market Trends
  • 8.5.2 Market Breakup by Country
  • 8.5.3 Market Forecast

9 SWOT Analysis

• 9.1 Overview
• 9.2 Strengths
• 9.3 Weaknesses
• 9.4 Opportunities
• 9.5 Threats

10 Value Chain Analysis

11 Porters Five Forces Analysis

• 11.1 Overview
• 11.2 Bargaining Power of Buyers
• 11.3 Bargaining Power of Suppliers
• 11.4 Degree of Competition
• 11.5 Threat of New Entrants
• 11.6 Threat of Substitutes

12 Price Indicators

13 Competitive Landscape

• 13.1 Market Structure
• 13.2 Key Players
• 13.3 Profiles of Key Players
  • 13.3.1 Allengers Medical Systems Limited
    • 13.3.1.1 Company Overview
    • 13.3.1.2 Product Portfolio
  • 13.3.2 Aurora Health Care Inc. (Schoen Clinic)
    • 13.3.2.1 Company Overview
    • 13.3.2.2 Product Portfolio
  • 13.3.3 Canon Inc.
    • 13.3.3.1 Company Overview
    • 13.3.3.2 Product Portfolio
    • 13.3.3.3 Financials
    • 13.3.3.4 SWOT Analysis
  • 13.3.4 Carestream Health Inc. (Onex Corporation)
    • 13.3.4.1 Company Overview
    • 13.3.4.2 Product Portfolio
    • 13.3.4.3 SWOT Analysis
  • 13.3.5 Delphinus Medical Technologies
    • 13.3.5.1 Company Overview
    • 13.3.5.2 Product Portfolio
  • 13.3.6 Dilon Technologies Inc.
    • 13.3.6.1 Company Overview
    • 13.3.6.2 Product Portfolio
  • 13.3.7 Fujifilm Holdings Corporation
    • 13.3.7.1 Company Overview
    • 13.3.7.2 Product Portfolio
    • 13.3.7.3 Financials
    • 13.3.7.4 SWOT Analysis
  • 13.3.8 GE Healthcare
    • 13.3.8.1 Company Overview
    • 13.3.8.2 Product Portfolio
    • 13.3.8.3 Financials
    • 13.3.8.4 SWOT Analysis
  • 13.3.9 Hologic Inc.
    • 13.3.9.1 Company Overview
    • 13.3.9.2 Product Portfolio
    • 13.3.9.3 Financials
    • 13.3.9.4 SWOT Analysis
  • 13.3.10 Koninklijke Philips N.V.
    • 13.3.10.1 Company Overview
    • 13.3.10.2 Product Portfolio
    • 13.3.10.3 Financials
    • 13.3.10.4 SWOT Analysis
  • 13.3.11 Micrima Limited
    • 13.3.11.1 Company Overview
    • 13.3.11.2 Product Portfolio
    • 13.3.11.3 Financials
  • 13.3.12 Planmed Oy
    • 13.3.12.1 Company Overview
    • 13.3.12.2 Product Portfolio
    • 13.3.12.3 Financials
  • 13.3.13 Siemens Healthineers AG (Cerner Corporation)
    • 13.3.13.1 Company Overview
    • 13.3.13.2 Product Portfolio
    • 13.3.13.3 Financials
  • 13.3.14 Toshiba Corporation
    • 13.3.14.1 Company Overview
    • 13.3.14.2 Product Portfolio
    • 13.3.14.3 Financials
    • 13.3.14.4 SWOT Analysis